Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations

Am J Hematol. 2021 Nov 1;96(11):E420-E423. doi: 10.1002/ajh.26325. Epub 2021 Aug 30.

Authors

Affiliations

¹ Department of Hematopathology, MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts, USA.
³ Department of Pathology, Weill-Cornell Medical Center, New York, New York, USA.
⁴ Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁵ Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

PMID: 34416041
DOI: 10.1002/ajh.26325

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Cohort Studies
Female
High-Throughput Nucleotide Sequencing
Humans
Male
Middle Aged
Mutation*
Myelodysplastic Syndromes / genetics*
Myelodysplastic Syndromes / pathology
Young Adult